Global and China Antiparasitic Drugs Market Size, Status and Forecast 2020-2026

Published On: Jul 2020

Format: PDF

Publisher: QY Research

Pages: 125

Report ID: 199236

Global Antiparasitic Drugs Scope and Market Size
Antiparasitic Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Antiparasitic Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.

Market segment by Type, the product can be split into
by Type
Anthelmintics
Antiprotozoals
Others
by Delivery Type
Oral
Injectable
Topical

Market segment by Application, split into
Hospital
Clinic
Others

Based on regional and country-level analysis, the Antiparasitic Drugs market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa

In the competitive analysis section of the report, leading as well as prominent players of the global Antiparasitic Drugs market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The key players covered in this study
Ipca Laboratories Ltd
Zydus Cadila
Merck
Pfizer
GlaxoSmithKline Plc.
Cipla Ltd
Ranbaxy Laboratories
Novartis AG
Alvizia Health Care
Bayer AG
Roche Inc
Arbor Pharmaceuticals Inc.
Sanofi
AstraZeneca
Alkem Laboratories Limited

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Antiparasitic Drugs Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Anthelmintics
1.2.3 Antiprotozoals
1.2.4 Others
1.3 Market by Application
1.3.1 Global Antiparasitic Drugs Market Share by Application: 2020 VS 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Antiparasitic Drugs Market Perspective (2015-2026)
2.2 Global Antiparasitic Drugs Growth Trends by Regions
2.2.1 Antiparasitic Drugs Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Antiparasitic Drugs Historic Market Share by Regions (2015-2020)
2.2.3 Antiparasitic Drugs Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Antiparasitic Drugs Players by Market Size
3.1.1 Global Top Antiparasitic Drugs Players by Revenue (2015-2020)
3.1.2 Global Antiparasitic Drugs Revenue Market Share by Players (2015-2020)
3.2 Global Antiparasitic Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Antiparasitic Drugs Revenue
3.4 Global Antiparasitic Drugs Market Concentration Ratio
3.4.1 Global Antiparasitic Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Antiparasitic Drugs Revenue in 2019
3.5 Key Players Antiparasitic Drugs Area Served
3.6 Key Players Antiparasitic Drugs Product Solution and Service
3.7 Date of Enter into Antiparasitic Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Antiparasitic Drugs Breakdown Data by Type (2015-2026)
4.1 Global Antiparasitic Drugs Historic Market Size by Type (2015-2020)
4.2 Global Antiparasitic Drugs Forecasted Market Size by Type (2021-2026)

5 Antiparasitic Drugs Breakdown Data by Application (2015-2026)
5.1 Global Antiparasitic Drugs Historic Market Size by Application (2015-2020)
5.2 Global Antiparasitic Drugs Forecasted Market Size by Application (2021-2026)

6 North America
6.1 North America Antiparasitic Drugs Market Size (2015-2026)
6.2 North America Antiparasitic Drugs Market Size by Type (2015-2020)
6.3 North America Antiparasitic Drugs Market Size by Application (2015-2020)
6.4 North America Antiparasitic Drugs Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada

7 Europe
7.1 Europe Antiparasitic Drugs Market Size (2015-2026)
7.2 Europe Antiparasitic Drugs Market Size by Type (2015-2020)
7.3 Europe Antiparasitic Drugs Market Size by Application (2015-2020)
7.4 Europe Antiparasitic Drugs Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe

8 China
8.1 China Antiparasitic Drugs Market Size (2015-2026)
8.2 China Antiparasitic Drugs Market Size by Type (2015-2020)
8.3 China Antiparasitic Drugs Market Size by Application (2015-2020)
8.4 China Antiparasitic Drugs Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific

9 Japan
9.1 Japan Antiparasitic Drugs Market Size (2015-2026)
9.2 Japan Antiparasitic Drugs Market Size by Type (2015-2020)
9.3 Japan Antiparasitic Drugs Market Size by Application (2015-2020)
9.4 Japan Antiparasitic Drugs Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil

10 Southeast Asia
10.1 Southeast Asia Antiparasitic Drugs Market Size (2015-2026)
10.2 Southeast Asia Antiparasitic Drugs Market Size by Type (2015-2020)
10.3 Southeast Asia Antiparasitic Drugs Market Size by Application (2015-2020)
10.4 Southeast Asia Antiparasitic Drugs Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa

11Key Players Profiles
11.1 Ipca Laboratories Ltd
11.1.1 Ipca Laboratories Ltd Company Details
11.1.2 Ipca Laboratories Ltd Business Overview
11.1.3 Ipca Laboratories Ltd Antiparasitic Drugs Introduction
11.1.4 Ipca Laboratories Ltd Revenue in Antiparasitic Drugs Business (2015-2020))
11.1.5 Ipca Laboratories Ltd Recent Development
11.2 Zydus Cadila
11.2.1 Zydus Cadila Company Details
11.2.2 Zydus Cadila Business Overview
11.2.3 Zydus Cadila Antiparasitic Drugs Introduction
11.2.4 Zydus Cadila Revenue in Antiparasitic Drugs Business (2015-2020)
11.2.5 Zydus Cadila Recent Development
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Antiparasitic Drugs Introduction
11.3.4 Merck Revenue in Antiparasitic Drugs Business (2015-2020)
11.3.5 Merck Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Antiparasitic Drugs Introduction
11.4.4 Pfizer Revenue in Antiparasitic Drugs Business (2015-2020)
11.4.5 Pfizer Recent Development
11.5 GlaxoSmithKline Plc.
11.5.1 GlaxoSmithKline Plc. Company Details
11.5.2 GlaxoSmithKline Plc. Business Overview
11.5.3 GlaxoSmithKline Plc. Antiparasitic Drugs Introduction
11.5.4 GlaxoSmithKline Plc. Revenue in Antiparasitic Drugs Business (2015-2020)
11.5.5 GlaxoSmithKline Plc. Recent Development
11.6 Cipla Ltd
11.6.1 Cipla Ltd Company Details
11.6.2 Cipla Ltd Business Overview
11.6.3 Cipla Ltd Antiparasitic Drugs Introduction
11.6.4 Cipla Ltd Revenue in Antiparasitic Drugs Business (2015-2020)
11.6.5 Cipla Ltd Recent Development
11.7 Ranbaxy Laboratories
11.7.1 Ranbaxy Laboratories Company Details
11.7.2 Ranbaxy Laboratories Business Overview
11.7.3 Ranbaxy Laboratories Antiparasitic Drugs Introduction
11.7.4 Ranbaxy Laboratories Revenue in Antiparasitic Drugs Business (2015-2020)
11.7.5 Ranbaxy Laboratories Recent Development
11.8 Novartis AG
11.8.1 Novartis AG Company Details
11.8.2 Novartis AG Business Overview
11.8.3 Novartis AG Antiparasitic Drugs Introduction
11.8.4 Novartis AG Revenue in Antiparasitic Drugs Business (2015-2020)
11.8.5 Novartis AG Recent Development
11.9 Alvizia Health Care
11.9.1 Alvizia Health Care Company Details
11.9.2 Alvizia Health Care Business Overview
11.9.3 Alvizia Health Care Antiparasitic Drugs Introduction
11.9.4 Alvizia Health Care Revenue in Antiparasitic Drugs Business (2015-2020)
11.9.5 Alvizia Health Care Recent Development
11.10 Bayer AG
11.10.1 Bayer AG Company Details
11.10.2 Bayer AG Business Overview
11.10.3 Bayer AG Antiparasitic Drugs Introduction
11.10.4 Bayer AG Revenue in Antiparasitic Drugs Business (2015-2020)
11.10.5 Bayer AG Recent Development
11.11 Roche Inc
10.11.1 Roche Inc Company Details
10.11.2 Roche Inc Business Overview
10.11.3 Roche Inc Antiparasitic Drugs Introduction
10.11.4 Roche Inc Revenue in Antiparasitic Drugs Business (2015-2020)
10.11.5 Roche Inc Recent Development
11.12 Arbor Pharmaceuticals Inc.
10.12.1 Arbor Pharmaceuticals Inc. Company Details
10.12.2 Arbor Pharmaceuticals Inc. Business Overview
10.12.3 Arbor Pharmaceuticals Inc. Antiparasitic Drugs Introduction
10.12.4 Arbor Pharmaceuticals Inc. Revenue in Antiparasitic Drugs Business (2015-2020)
10.12.5 Arbor Pharmaceuticals Inc. Recent Development
11.13 Sanofi
10.13.1 Sanofi Company Details
10.13.2 Sanofi Business Overview
10.13.3 Sanofi Antiparasitic Drugs Introduction
10.13.4 Sanofi Revenue in Antiparasitic Drugs Business (2015-2020)
10.13.5 Sanofi Recent Development
11.14 AstraZeneca
10.14.1 AstraZeneca Company Details
10.14.2 AstraZeneca Business Overview
10.14.3 AstraZeneca Antiparasitic Drugs Introduction
10.14.4 AstraZeneca Revenue in Antiparasitic Drugs Business (2015-2020)
10.14.5 AstraZeneca Recent Development
11.15 Alkem Laboratories Limited
10.15.1 Alkem Laboratories Limited Company Details
10.15.2 Alkem Laboratories Limited Business Overview
10.15.3 Alkem Laboratories Limited Antiparasitic Drugs Introduction
10.15.4 Alkem Laboratories Limited Revenue in Antiparasitic Drugs Business (2015-2020)
10.15.5 Alkem Laboratories Limited Recent Development

12Analyst's Viewpoints/Conclusions

13Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details